Pre-Research Assessment: Complete medical history and physical review Baseline blood glucose and HbA1c Liver function tests (ALT, AST, bilirubin) Renal function tests (creatinine, BUN, eGFR) Complete blood count Lipid panel IGF-1 and IGFBP-3 levels Thyroid function tests Screening for contraindications During Research Tracking: Regular blood glucose tracking (frequency based on dose and risk factors) Periodic assessment of liver and renal function Tracking for signs of fluid retention Assessment of injection sites Records of any adverse findings Regular evaluation of research parameters Post-Research Assessment: Repeat baseline laboratory tests Evaluation of any persistent effects Assessment of research outcomes Planning of appropriate follow-up Managing Adverse Observations Research protocols should include plans for managing possible adverse findings
Most people regain significant weight after stopping either Zepbound or Wegovy
Having megaloblastic anemia can make you more at risk of suffering from osteoporosis, problems with your vision, struggle with memory, worsened cognitive functioning, and if you were to become pregnant, it increases the risk of birth defects in the fetus
The FDA labels for these pills explicitly note this concern
Y., He, Q
Right now, the key questions are about investigational status, supervised access routes, and how to judge risk versus cost
